Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9658022 | 0.97 | LMNA (0.35) | LMNA | |
| SCHEMBL9659326 | 0.97 | LMNA (0.35) | LMNA | |
| SCHEMBL31621174 | 0.97 | LMNA (0.35) | LMNA | |
| SCHEMBL31621182 | 0.97 | LMNA (0.35) | LMNA | |
| SCHEMBL31621171 | 0.97 | LMNA (0.35) | LMNA | |
| SCHEMBL31621180 | 0.97 | LMNA (0.35) | LMNA | |
| SCHEMBL31621172 | 0.97 | LMNA (0.35) | LMNA | |
| SCHEMBL31621176 | 0.97 | LMNA (0.35) | LMNA | |
| SCHEMBL31621181 | 0.97 | LMNA (0.35) | LMNA | |
| SCHEMBL9343785 | 0.87 | LMNA (0.32) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120157105-A | Method for defluorination of perfluoro and polyfluoroalkyl substances | 中国科学技术大学 | 2025-06-17 | — | — | CN | disclosed |
| US-9082985-B2 | Arylsulfonic acid compound and use thereof as electron-acceptor material | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-07-14 | — | — | US | disclosed |
| EP-2246325-B1 | ARYLSULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | NISSAN CHEMICAL IND LTD (JP) | 2013-11-06 | — | — | EP | disclosed |
| US-20130240795-A1 | ARYLSULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-09-19 | — | — | US | disclosed |
| EP-2620427-A1 | Arylsulfonic Acid Compound And Use Thereof As Electron-Acceptor Material | Nissan Chemical Industries, Ltd. (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-8460582-B2 | Arylsulfonic acid compound and use thereof as electron-acceptor material | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-06-11 | — | — | US | disclosed |
| US-20100320422-A1 | ARYLSULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
| EP-2246325-A1 | ARYLSULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | Nissan Chemical Industries, Ltd. (JP) | 2010-11-03 | — | — | EP | disclosed |
| EP-0628019-B1 | POLYFLUOROALKYLATION OF AROMATIC COMPOUNDS | DU PONT (US) | 1997-04-23 | — | — | EP | disclosed |
| EP-0628019-A1 | POLYFLUOROALKYLATION OF AROMATIC COMPOUNDS. | DU PONT (US) | 1994-12-14 | — | — | EP | disclosed |
| US-5276194-A | Reacting perfluoroalkyl iodide with aromatic compound in presence of aqueous inorganic base | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-01-04 | — | — | US | disclosed |
| WO-1993016969-A1 | POLYFLUOROALKYLATION OF AROMATIC COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100320422-A1 | ARYLSULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | ELOVL6, ELOVL1, ARSA | LMNA 4133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.